Schedule 13D ownership disclosure

Protagenic Therapeutics, Inc.\new

Security class unavailable · CUSIP: 74365N103

Event date: 2020-02-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
37.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-20-003168
Form type
SC 13D/A
Filer
ARMEN GARO H
CIK
CIK 935679
Filed
Feb 28, 2020
Reporting period
Feb 21, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub